Skip to main content
CELU
NASDAQ Life Sciences

Celularity Amends Senior EVP's Employment Agreement, Enhancing Severance and Accelerating Option Vesting

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$1.25
Mkt Cap
$36.047M
52W Low
$1.001
52W High
$4.35
Market data snapshot near publication time

Summary

Celularity Inc. has amended the employment agreement for its Senior Executive Vice President, John Haines, significantly increasing his severance period and accelerating the vesting of equity options upon termination.


Key Events

  • Executive Employment Agreement Amended

    Celularity Inc. approved the First Amendment to the employment agreement of John Haines, Senior Executive Vice President, Global Manager and Chief Administrative Officer.

  • Enhanced Severance Terms

    The severance period for Mr. Haines was increased from 12 months to 24 months, and COBRA payment was extended to 18 months.

  • Accelerated Equity Vesting

    Equity options that would have vested over a 24-month period after termination will now vest immediately upon termination.


Analysis

The amendment to John Haines' employment agreement, a Senior Executive Vice President and Chief Administrative Officer, is notable for Celularity Inc., a micro-cap company. The changes, which include doubling the severance period to 24 months and immediately vesting 24 months of equity options upon termination, increase the company's potential financial obligations in the event of an executive departure. This could be interpreted as a 'golden parachute' provision, potentially impacting future shareholder value through increased costs or dilution.

At the time of this filing, CELU was trading at $1.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36M. The 52-week trading range was $1.00 to $4.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CELU - Latest Insights

CELU
Jun 04, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.02
Real-time Price: $0.8565 info
Change: -$0.1635 (-16%) info
Market Cap: $24.792M info
CELU
Jun 03, 2026, 5:22 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $0.8565 info
Change: -$0.1935 (-18%) info
Market Cap: $24.792M info
CELU
May 28, 2026, 4:54 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.991
Real-time Price: $0.8565 info
Change: -$0.1345 (-14%) info
Market Cap: $24.792M info
CELU
May 01, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.02
Real-time Price: $0.8565 info
Change: -$0.1636 (-16%) info
Market Cap: $24.792M info
CELU
Apr 22, 2026, 10:16 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.22
Real-time Price: $0.8565 info
Change: -$0.3635 (-30%) info
Market Cap: $24.792M info
CELU
Apr 21, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.21
Real-time Price: $0.8565 info
Change: -$0.3535 (-29%) info
Market Cap: $24.792M info
CELU
Apr 03, 2026, 11:08 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.33
Real-time Price: $0.8565 info
Change: -$0.4735 (-36%) info
Market Cap: $24.792M info
CELU
Mar 10, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.29
Real-time Price: $0.8565 info
Change: -$0.4335 (-34%) info
Market Cap: $24.792M info
CELU
Mar 05, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $0.8565 info
Change: -$0.3435 (-29%) info
Market Cap: $24.792M info
CELU
Jan 21, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.25
Real-time Price: $0.8565 info
Change: -$0.3935 (-31%) info
Market Cap: $24.792M info